Table 4 Donor information for the validation set

T6

58

F

Pancreatic adenocarcinoma

IV

T7

53

M

Pancreatic adenocarcinoma

III

T8

64

M

Pancreatic adenocarcinoma

II

T9

51

M

Pancreatic adenocarcinoma

III

T10

64

F

Pancreatic adenocarcinoma

III

T11

81

M

Pancreatic adenocarcinoma

III

T12

59

M

Pancreatic adenocarcinoma

II

T13

63

M

Pancreatic adenocarcinoma

III

T14

69

M

Pancreatic adenocarcinoma

III

T15

48

M

Pancreatic adenocarcinoma

III

T16

67

M

Pancreatic adenocarcinoma

IV

T17

56

M

Pancreatic adenocarcinoma

IV

T18

37

F

Pancreatic adenocarcinoma

III

T19

58

F

Pancreatic adenocarcinoma

III

T20

52

F

Pancreatic adenocarcinoma

IV

T21

62

F

Pancreatic adenocarcinoma

I

N6

45

F

Serous cystic pancreatic neoplasm

N7

54

F

Somatostatin cell tumor

N8

60

M

Islet cell tumor

N9

54

M

Mucinous cystic pancreatic neoplasm

N10

36

M

Pseudocyst

N11

36

F

Serous cystic pancreatic neoplasm

N12

70

M

Pseudocyst

N13

53

M

Pancreatitis

N14

59

F

Pancreatitis

N15

50

F

Chronic pancreatitis

N16

48

F

Intraductal papillary mucinous neoplasm

N17

37

F

Normal

N18

54

M

Normal

N19

64

M

Normal

N20

72

M

Normal

N21

56

F

Normal